Coloplast shares tumble nearly 4% after the Danish medical device company misses expectations with its fiscal 2nd-quarter profits.
(Reuters) — Coloplast (CPH:COLO B) reported a 16% increase in 2nd-quarter core profit, slightly below expectations, pushing the medical device company's share price down nearly 4%.
The federal judge overseeing some 70,000 pelvic mesh product liability lawsuits urges the plaintiffs and the medical device company defendants to settle.
(Reuters) — A U.S. judge Thursday urged transvaginal mesh device makers and the women suing them to work harder to resolve their 10s of thousands of lawsuits in 1 of the biggest U.S. mass torts in history.
Coloplast posts its 1st profits decline in 7 years on mounting legal costs stemming from U.S. product liability lawsuits filed over its pelvic mesh products.
The Philadelphia Court of Common Pleas establishes a mass tort for all pelvic mesh lawsuits filed in its jurisdiction.
A Pennsylvania state judge ordered the creation of a mass tort this week to collect product liability lawsuits filed over pelvic mesh products against some of the largest names in medical devices.
Coloplast shares are up nearly 8% since the Danish medical device company reported its 4th-quarter and fiscal 2013 results.
Coloplast (CPH:COLO B) shares have gained nearly 8% since the Danish medical device company reported profit growth of more than 23% for the fiscal 4th quarter and 2013 last week.
A federal judge in West Virginia sets a date early next year for the 1st bellwether case in the multi-district litigation filed over Boston Scientific's pelvic mesh products.
The 1st bellwether trial in the multi-district litigation filed over Boston Scientific's (NYSE:BSX) pelvic mesh products is slated for early next year, a federal judge ordered this week.
Makers of pelvic mesh facing 10s of thousands of lawsuits over the surgical devices are hoping to negotiate bulk settlements with a consortium of plaintiffs' lawyers, according to Bloomberg.
Five medical device companies that make pelvic mesh implants are hoping to negotiate settlements for the more than 30,000 pending lawsuits they're facing in the U.S., anonymous sources told Bloomberg.